Systems biology: Opening new avenues in clinical research

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1015-1018

  Molina, Franck ^a   Dehmer, Matthias ^b   Perco, Paul ^c,d   Graber, Armin ^b   Girolami, Mark ^e   Spasovski, Goce ^f   Schanstra, Joost P ^g,h   Vlahou, Antonia ⁱ  

^a UMR 3145 SysDiag CNRS/Bio Rad   (France)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^c Emergentec Biodevelopment GmbH   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^g INSERM   (France)

^h UNIVERSITÉ DE TOULOUSE   (France)

ⁱ BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Biological networks; Biomedical informatics; Functional genomics; Personalized medicine; Systems biology

Indexed keywords

MICRORNA; PROTEOME;

CLINICAL RESEARCH; DATA BASE; METABOLOME; MINING; NOTE; PRIORITY JOURNAL; QUALITY CONTROL; SYSTEMS BIOLOGY; VALIDATION STUDY;

BIOMEDICAL RESEARCH; HUMANS; SYSTEMS BIOLOGY;

EID: 77950221000     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq033     Document Type: Note

References (30)

1. Uhlenhaut NH, Treier M. Transcriptional regulators in kidney disease: gatekeepers of renal homeostasis. Trends Genet 2008; 24: 361-371
2. Scharpé J, Maes B, Van Damme B. The podocyte: from bench to bedside. Acta Clin Belg 2005; 60: 86-93
3. Hurst RE. Does the biomarker search paradigm need re-booting? BMC Urol 2009; 9: 1
4. Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006; 24: 971-983
5. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006; 103: 5923-5928
6. Ahn AC, Tewari M, Poon C-S, et al. The limits of reductionism in medicine: could systems biology offer an alternative? PLoS Med 2006; 3: e208
7. Kitano H. Systems biology: a brief overview. Science 2002; 295: 1662-1664
8. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008; 4: 682-690
9. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome Med 2009; 1: 2
10. Kohl P, Noble D. Systems biology and the virtual physiological human. Mol Syst Biol 2009; 5: 292
11. Wheelock CE, Wheelock AM, Kawashima S, et al. Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol BioSyst 2009; 5: 588-602
12. Schadt EE, Zhang B, Zhu J. Advances in systems biology are enhancing our understanding of disease and moving us closer to novel disease treatments. Genetica 2009; 136: 259-269
13. Mischak H, Apweiler R, Banks RE, et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl 2007; 1: 148-156
14. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for mi-croarray data. Nat Genet 2001; 29: 365-371
15. JT, Tibshirani R, Deshpande T, et al. Disease signatures are robust across tissues and experiments. Mol Syst Biol 2009; 5: 307
16. Perco P, Rapberger R, Siehs C, et al. Transforming omics data into context: bioinformatics on genomics and proteomics raw data. Elec-trophoresis 2006; 27: 2659-2675
17. Meier S, Gehring C. A guide to the integrated application of on-line data mining tools for the inference of gene functions at the systems level. Biotechnol J 2008; 3: 1375-1387
18. Bauer-Mehren A, Furlong LI, Sanz F. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 2009; 5: 290
19. Emmert-Streib F, Dehmer M. Analysis of Microarray Data: A Network-based Approach. Weinheim, Germany: Wiley-VCH, 2008
20. Viswanathan GA, Seto J, Patil S, et al. Getting started in biological pathway construction and analysis. PLoS Comput Biol 2008; 4: e16
21. Bernthaler A, Mühlberger I, Fechete R, et al. A dependency graph approach for the analysis of differential gene expression profiles. Mol Biosyst 2009; 5: 1720-1731
22. Perco P, Wilflingseder J, Bernthaler A, et al. Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective. J Cell Mol Med 2008; 12: 1177-1187
23. Ishii N, Nakahigashi K, Baba T, et al. Multiple high-throughput analyses monitor the response of E. coli to perturbations. Science 2007; 316: 593-597
24. Zhu J, Zhang B, Smith EN, et al. Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 2008; 40: 854-861
25. Markowetz F, Spang R. Inferring cellular networks-a review. BMC Bioinformatics 2007; 8: S5
26. Schlitt T, Brazma A. Current approaches to gene regulatory network modelling. BMC Bioinformatics 2007; 8: S9
27. Endler L, Rodriguez N, Juty N, et al. Designing and encoding models for synthetic biology. J R Soc Interface 2009; 6: S405-S417
28. Santos SD, Verveer PJ, Bastiaens PI. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 2007; 9: 324-330
29. Ng A, Bursteinas B, Gao Q, et al. Resources for integrative systems biology: from data through databases to networks and dynamic system models. Brief Bioinform 2006; 7: 318-330
30. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526